These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12239963)

  • 1. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis.
    Tajiri T; Onda M; Yoshida H; Mamada Y; Taniai N; Kumazaki T
    Hepatogastroenterology; 2002; 49(47):1445-8. PubMed ID: 12239963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
    Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
    Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term follow-up for patients with liver cirrhosis after partial splenic embolization.
    Murata K; Shiraki K; Takase K; Nakano T; Tameda Y
    Hepatogastroenterology; 1996; 43(11):1212-7. PubMed ID: 8908553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial splenic embolization for the treatment of hypersplenism in cirrhosis.
    Sangro B; Bilbao I; Herrero I; Corella C; Longo J; Beloqui O; Ruiz J; Zozaya JM; Quiroga J; Prieto J
    Hepatology; 1993 Aug; 18(2):309-14. PubMed ID: 8340060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transradial approach for partial splenic embolization in patients with hypersplenism.
    Naritaka Y; Shiozawa S; Shimakawa T; Wagatsuma Y; Tsuchiya A; Kim DH; Isohata N; Asaka S; Yoshimatsu K; Katsube T; Ogawa K
    Hepatogastroenterology; 2007 Sep; 54(78):1850-3. PubMed ID: 18019733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and effect of two-step portal vein embolization in treatment of hepatic fibrosis: experiment with rabbits].
    Chen ZZ; Yang RJ; Liu PC
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):859-62. PubMed ID: 17565875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia.
    Ohmoto K; Yamamoto S
    Hepatogastroenterology; 2003; 50(54):1766-9. PubMed ID: 14696400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial splenic embolization: 12-month hematological effects and complications.
    Wang HY; Shih SC; Lin SC; Chang WS; Wang TE; Lin FJ; Yang FS
    Hepatogastroenterology; 2008; 55(86-87):1838-42. PubMed ID: 19102404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy improves liver function in patients with liver cirrhosis.
    Murata K; Ito K; Yoneda K; Shiraki K; Sakurai H; Ito M
    Hepatogastroenterology; 2008; 55(85):1407-11. PubMed ID: 18795700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results of the embolization of the hepatic and splenic arteries in liver cirrhosis].
    Granov AM; Ryzhkov VK; Tarazov PG
    Khirurgiia (Mosk); 1991 Nov; (11):84-8. PubMed ID: 1779561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial splenic embolization decreases the serum bilirubin level in patients with hypersplenism following the Kasai procedure for biliary atresia.
    Ando H; Ito T; Nagaya M
    J Am Coll Surg; 1996 Mar; 182(3):206-10. PubMed ID: 8603238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis.
    Gu JJ; He XH; Li WT; Ji J; Peng WJ; Li GD; Wang SP; Xu LC
    Acta Radiol; 2012 Oct; 53(8):862-7. PubMed ID: 22855417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis].
    Nomiyama K; Akagi K; Watanabe H; Kajiwara E; Sakino I
    Fukuoka Igaku Zasshi; 1991 Mar; 82(3):105-9. PubMed ID: 2066049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up results of splenic artery embolization in liver cirrhosis].
    Tarazov PG
    Khirurgiia (Mosk); 2000; (3):18-20. PubMed ID: 10761376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical removal of renal cell carcinoma after partial splenic embolization in a patient with liver cirrhosis: a case report].
    Makiyama K; Senga Y; Gotou A; Sakuramoto T; Hata Y
    Hinyokika Kiyo; 2000 Dec; 46(12):895-8. PubMed ID: 11211807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.
    Hayashi H; Beppu T; Masuda T; Mizumoto T; Takahashi M; Ishiko T; Takamori H; Kanemitsu K; Hirota M; Baba H
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1638-42. PubMed ID: 17683504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism.
    Chikamori F; Kuniyoshi N; Kawashima T; Takase Y
    Hepatogastroenterology; 2007 Sep; 54(78):1847-9. PubMed ID: 18019732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.
    Noguchi H; Hirai K; Aoki Y; Sakata K; Tanikawa K
    Hepatology; 1995 Dec; 22(6):1682-8. PubMed ID: 7489974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for complications after partial splenic embolization for liver cirrhosis.
    Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Baba H
    Br J Surg; 2008 Jun; 95(6):744-50. PubMed ID: 18412294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.